CEO acquires Series C Preferred shares with super-voting rights; approved 3.5x increase in authorized shares

Hypha Labs, Inc.

On Dec 10, 2024, CEO A. Stone Douglass purchased 1,000 shares of Series C Preferred at $0.10/share, each carrying 200,000 votes.
Series C shares are not convertible, pay no dividends, are non-redeemable, and have a $0.10/share liquidation preference.
Purpose: to allow CEO to vote a majority to amend Articles to increase authorized common from 250M to 880M and preferred from 10M to 70M.
Amendment approved by written consent of CEO as sole Series C holder; effective upon filing with Nevada Secretary of State.
Sale was exempt from registration under Section 4(a)(2) of the Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.